OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 2.

MIC and MBC data for SPR719 against clarithromycin-resistant and amikacin-resistant clinical NTM isolates

NTM species N of isolates with indicated MIC (µg/mL) MIC range (µg/mL) MIC50 (µg/mL) MIC90 (µg/mL)
0.031 0.062 0.125 0.25 0.5 1 2 4 8 16 >16
Clarithromycin-resistant isolates (N=57)
Mycobacterium avium (N=10) 3 (30) 2 (20) 3 (30) 1 (10) 1 (10) 0.5–8 1 8
M. intracellulare (N=17) 1 (6) 3 (18) 6 (35) 3 (17) 2 (12) 2 (12) 0.062–8 1 8
M. abscessus (N=13) 1 (8) 2 (15) 6 (47) 2 (15) 2 (15) 0.062–4 1 4
M. massiliense (N=17) 2 (12) 1 (6) 4 (23) 4 (23) 2 (12) 2 (12) 2 (12) 0.062–4 0.5 4
Amikacin-resistant isolates (N=44)
M. avium (N=12) 7 (59) 4 (33) 1 (8) 1–8 1 2
M. intracellulare (N=17) 4 (24) 6 (35) 5 (29) 2 (12) 0.5–4 1 4
M. abscessus (N=9) 1 (11) 7 (78) 1 (11) 1–4 2 4
M. massiliense (N=6) 3 (50) 2 (33) 1 (17) 0.5–2 0.5 2
N of isolates with indicated MBC (µg/mL) MBC range (µg/mL) MBC50 (µg/mL) MBC90 (µg/mL)
0.031 0.062 0.125 0.25 0.5 1 2 4 8 16 >16
Clarithromycin-resistant isolates (N=57)
M. avium (N=10) 2 (20) 2 (20) 4 (40) 1 (10) 1 (10) 0.5–8 2 8
M. intracellulare (N=17) 1 (6) 2 (12) 5 (29) 5 (29) 2 (12) 1 (6) 1 (6) 0.25–16 1 8
M. abscessus (N=13) 3 (23) 6 (46) 4 (31) 2–8 4 8
M. massiliense (N=17) 4 (23) 2 (12) 3 (18) 3 (18) 5 (29) 0.25–4 1 4
Amikacin-resistant isolates (N=44)
M. avium (N=12) 6 (50) 4 (34) 1 (8) 1 (8) 1–8 1 4
M. intracellulare (N=17) 1 (6) 6 (35) 7 (41) 1 (6) 2 (12) 0.5–8 2 8
M. abscessus (N=9) 1 (11) 7 (78) 1 (11) 2–8 4 8
M. massiliense (N=6) 4 (67) 2 (33) 1–2 1 2

Data are presented as number (%).

Abbreviations: MIC, minimum inhibitory concentration; MIC50, minimum concentration required to inhibit 50% of bacteria; MIC90, minimum concentration to inhibit 90% of bacteria; MBC, minimum bactericidal concentration; MBC50, minimum concentration required to kill 50% of bacteria; MBC90, minimum concentration required to kill 90% of bacteria; NTM, nontuberculous mycobacteria.

© Ann Lab Med